Acadian Asset Management »

Achilles Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $218k 192k 1.14
2024-09-30 $255k 251k 1.02
2024-06-30 $203k 251k 0.81
2024-03-31 $350k 281k 1.25
2022-09-30 $2.0k 1.3k 1.58

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Booking Holdings (BKNG)
JPMorgan Chase & Co. (JPM)
Deutsche Bank A G Namen Akt (DB)
Ubs Group SHS (UBS)
Logitech Intl S A SHS (LOGI)
Broadcom Ord Shs (AVGO)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)

View all positions for Acadian Asset Management

Top funds holding Achilles Therapeutics

Rhumbline Advisers
GAMMA Investing

View all funds holding Achilles Therapeutics